SureTrader
Home > Boards > US OTC > Miscellaneous >

EP Global Communications, Inc. (EPGL)

EPGL RSS Feed
Add EPGL Price Alert      Hide Sticky   Hide Intro
Moderator: Atlanta1, flaflyersfan, Doubledown22, Stock Barber, baryoboy, KBing617
Search This Board:
Last Post: 2/9/2016 9:01:52 PM - Followers: 462 - Board type: Free - Posts Today: 95
 

                        


About the Company:

EP Global Communications, Inc. is an Advanced Technology Research and Development company for both Medical Devices and Consumer Electronics Devices specializing in Microelectronic Mechanical Systems (MEMS). For more information about the company, please click on the banner above to be directed to the comapny website.

People, Products & Process:
EPGL has assembled an impressive team to propel the company into a bright future and to build shareholder value. Under the leadership of Michael Hayes EPGL underwent debt restructuring, assembly of a new management team, as well as medical and scientific personnel. Mr. Hayes has made it a singular priority to bring aboard only the world’s top professionals in the field of medical sciences to EPGL and thereby build the Company into a major player in the Medical Device Industry over the next several years. He has also committed to prioritizing shareholders and creating significant value for their investment over time. We have seen great evidence of the har work over the last couple years as EPGL has signed Development Agreements with CooperVision, Intel, and AT&T. EPGL is in negotiations to licence technology to CooperVision presently. On April 28th 2015, EPGL disclosed to shareholders that
EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties. Shareholders can expect developments on this in the near future.


One key team member that was brought on board is David Markus (Vice President, BioMEMS) Developer, As you will see David Markus is a Well Accomplished Engineer.

David T. Markus holds a Ph.D. in Biomedical Engineering and a MS in Electrical Engineering with an emphasis in MEMS Microelectronics and Biomedical. Dr. Markus spent 11 years with Raytheon and holds 8 US patents and has 9 other US Patents Pending. He has been involved in research for several of the world's leading technological institutions, including the Office of Naval Research in Arlington, Virginia, NASA Jet Propulsion Laboratory in Pasadena, CA and he has been published 15 times for various technical conferences. He was a principal investigator on SBIR DARPA Phase I and Phase II, and "Ultraflexible Substrate" for Macroelectronics Program by Dr. Robert Reuss at DARPA. He has been involved in the engineering and the development on seven surgical devices, including devices for Cataract surgery, Intra-Ocular Lens Delivery, Arthroscopy, Endodontic Endoscope, Micro Endoscope and Neural Electrodes. Additionally he was instrumental on developing three medical laboratory devices, including for In-Vitro Fertilization, PCR instrumentation and drug discovery.

The Company has significant know-how and Intellectual Property in the arena of BioMEMS and has invented new device technologies which include, but are not limited to the following:
 
1. Advanced Power Source for Contact Lenses 11. Advanced TopSpin Platform Technology for Development of Smart Medical Devices
2. Advanced Cell Regeneration Technology to Treat Eye Disease 12. Advanced Device for Steam Cell Treatment Delivery
3. Advanced Cell Regeneration Technology to Treat Hearing Loss 13. Advanced Device for Treatment of Prostate Tumors
4. Advanced Nerve Ablation Device 14. Advanced Endoscopic Device
5. Advanced Epidural Device 15. Advanced Device for Delievery of Micron Sized Drug Payloads
6. New & Promsing Treatment of Restinitis Pigmentosa 16. New & Promising Device for Treatment of Macular Degeneration
7. Advanced Ablation Device for Nerve Treatment of Facial Glabballar Frownig 17. New Advanced Contact Lens Device
8. New Advanced PowerSource for TopSpin Medical Devices 18. Advanced Device For Delivery of Micro Mechanical Devices Into Body
9. Advanced Trigger Point Needle Device 19.  Device for  Advanced Biopsy
10. Advanced Micron Resolution Motor for Smart Medical Devices 20. Real-Time Sensor Technologies for Connectivity to a Global Network  **NEW
21.Real-Time Data Applications for Athletic Teams, Workforces and Military Forces*NEW
 
EPGL develops advanced technololgies and in negotiations currently to license them to medical device companies and consumer electronic companies.

Contract with CooperVision:
EPGL and CooperVision, Inc. (CooperVision) have signed an exclusive Development Agreement for Advanced Ophthalmic and Medical Technologies. CooperVision is a market leader in the manufacturing and marketing of contact lenses. The Cooper Companies recently completed the acquisition of Sauflon Pharmaceuticals Limited for approximately $1.2 Billion Dollars.

Material Disclosure to Shareholdrs EPGL MED JOINT PATENT VALIDATION
(Includes EPGL MED, COOPERVISION, David T.Markus, Aurthur Back, Luke A.Kilyk, Michael Hayes)

https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=141220

CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B Ophthalmic Technologies Discoveries Could Revolutionize the Future of Eye Care
http://www.prnewswire.com/news-releases/coopervision-inc-seeks-intermediary-as-ep-global-communications-inc-opens-negotiations-at-11b-300057706.html

CooperVision, Inc. Asks EP Global Communications, Inc. to Grant Option to License Immediately EPGL Considering its Options in Light of the Early Request
http://www.prnewswire.com/news-releases/coopervision-inc-asks-ep-global-communications-inc-to-grant-option-to-license-immediately-300050979.html

Exclusive Development Agreement Signed with CooperVision, Inc., a Division of The Cooper Companies, Inc. (COO, NYSE)
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=125904



Contract with Intel:
On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an Initial Agreement. Additional Agreements are now pending. EPGL management believes that a relationship with Intel will be advantageous to shareholders as the two companies have synergistic goals in various fields. Details of further Agreements will be available upon mutual decision of the parties to disclose them publicly.

On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an initial Agreement. Additional Agreements are now pending.
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=127990
 


Contract with AT&T: 
A new Development Agreement has been executed between AT&T and EPGL on January 4, 2015. As a result of this agreeement Joint Intellectual Properties are now being developed certain data streaming projects in mind. EPGL continues to create new and innovative technologies with large companies
New** EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties (4/28/15)
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=136848

EPGL and AT&T Developing Joint Intellectual Properties Companies Sign Development Agreement Resulting in New Inventions in IoT Data Streaming Space
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=133983

EPGL and AT&T Sign Development Agreement
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=132040



About EPGL Medical Science's Share Structure :

EPGL has a share structure of 5 billion authorized shares with approximately 4.5 billion shares restricted and a float of approximately 499 million. Following a very successful Reverse Split EPGL has decreased the float by 90% and increased share holder value by over 500% since that time. The company has strongly stated many times that they will not sell shares into the retail market. They are here to build a real company and implement real growth. Since restructuring EPGL has not increased the Float/OS/AS and have given us there word on countless occasions they will not do so. As of Start of January 2015 Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares.  Reduction of A/S and O/S is currently ongoing and first evidence of EPGL reducing shares will be shown in upcoming Quartley Report  Q3, 2015
LINKS TO SHARE RETIREMENT
** Press Release **  - Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares Beginning January 2015

** OTC Disclosure ** - Supplemental Information- Retirement of Common Shares by Beneficial Shareholders Commences

Pricewaterhouse Coopers, Corporate Finance and Recovery (Cayman) Ltd.Controlling Agent for:
AJW Qualified Partners, LLC, Controlled by PwC (PricewaterhouseCoopers) Worlds Largest Accounting Firm
1.975 Billion Common Shares
Mr. Michael Hayes
1.975 Billion Common Shares
FLOAT/TRADABLE SHARES : 499 Million ***Unchanged since Restruture in 2012***
Total number of shareholders of record 700 approximate 

ISSUERS FACILITIES
The Company leases or utilizes facilities in the following locations

Various California Bay Area Research Facilities Under NDA, David T. Markus, Ph.D.

Irvine, California – Research Facilities, Office

New York University Langone Medical Center, Corey W. Hunter M.D. / Eric Lee M.D.

University of Minnesota, David T. Markus, Ph.D.

University of California at Irvine, David T. Markus, Ph.D.

Dallas and Plano Texas, David T. Markus, Ph.D. **NEW**




Additional Information :
Letter From PricewaterhouseCoopers (Ian Stokoe) Congratulating EPGL on First  Devlopment Agreement (CooperVision)

Follow EPGL on Twiter @epglMED  https://twitter.com/EPGLMed
Follow EPGL on the WEB at http://www.epglmed.com





 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
EPGL
Current Price
Volume:
Bid Ask Day's Range
Wiki
PostSubject
#97811  Sticky Note EP Global Communications, Inc. Reaches Settlement Agreement with vikingzskillz 02/09/16 02:25:24 PM
#97386  Sticky Note $EPGL Facts- Published Patent Apps, Tweets, Pictures, Confirmations vikingzskillz 02/02/16 08:20:04 AM
#95482  Sticky Note Press releases or other company communication should not IH Admin [Brian] 01/12/16 12:14:18 PM
#97861   Well it should be very easy to provide Doubledown22 02/09/16 09:01:52 PM
#97860   grow with applications then patents, grow with next franck92 02/09/16 08:44:00 PM
#97859   grow? Atlanta1 02/09/16 08:17:52 PM
#97858   Done nothing but grow. New investors will H8ster 02/09/16 08:16:53 PM
#97857   $EPGL cominues to grow, got to like real companies. vikingzskillz 02/09/16 08:00:00 PM
#97856   " To ignore those applications and write them skorz 02/09/16 07:58:35 PM
#97855   no, it's not. Atlanta1 02/09/16 07:40:23 PM
#97854   I'm not so sure AR/VR and medical devices Scutterflux 02/09/16 07:35:46 PM
#97853   No it hasn't. Scutterflux 02/09/16 07:28:16 PM
#97852   Agree 100%, spot on H8ster! vikingzskillz 02/09/16 07:27:03 PM
#97851   That "PR" originated from Hayes. There is Koog 02/09/16 07:25:27 PM
#97850   So, that's your verification? The fact that Intel H8ster 02/09/16 07:21:10 PM
#97849   What's his name and email? Valiant 02/09/16 07:20:16 PM
#97847   It is more logical that the shareholders protect franck92 02/09/16 07:01:51 PM
#97846   Oh, I got a denial all right. Koog 02/09/16 07:00:47 PM
#97845   No Denial is a No comment franck92 02/09/16 06:59:08 PM
#97844   If I inquired about a company that WAS Koog 02/09/16 06:55:23 PM
#97843  Restored So, that's your verification? The fact that H8ster 02/09/16 06:50:48 PM
#97840   What is his name again? And email Valiant 02/09/16 06:45:25 PM
#97839   Initial agreement. Ha! That confirms they Koog 02/09/16 06:39:20 PM
#97838   Intel has never come out and said they don't Koog 02/09/16 06:37:01 PM
#97837   The world of BioMEM/Wearable/IoT is huge. EPGL H8ster 02/09/16 06:24:18 PM
#97836   We will be rewarded Yeeeepppeeeeeeeeeee franck92 02/09/16 06:24:11 PM
#97835   They do. They have an Initial Agreement H8ster 02/09/16 06:19:22 PM
#97834   They have an Initial Agreement in place. H8ster 02/09/16 06:15:59 PM
#97833   Haha. But Intel may have something to Valiant 02/09/16 06:12:57 PM
#97832   This is something that all long term shareholders H8ster 02/09/16 06:07:15 PM
#97830   This company has NOTHING to do with Intel Koog 02/09/16 06:06:29 PM
#97829   Yep! Doesn't take a whole lot of H8ster 02/09/16 06:03:32 PM
#97828   EPGL is a legitimate company verified by AT&T, Mrzach3590 02/09/16 05:56:26 PM
#97825   Trying to convince me there is no sun Valiant 02/09/16 05:01:42 PM
#97824   yeah baby!!!!! Multiday runner coming! !!!! Get in IloveTransformers1984 02/09/16 05:01:00 PM
#97822   most sells , painted green with few bucks nowy257 02/09/16 04:43:32 PM
#97821   Better than previous rampage tweets!! irbaboon 02/09/16 04:40:17 PM
#97820   It was indeed the best outcome for investors H8ster 02/09/16 04:33:21 PM
#97819   OMP pps is UP Lol. trend is changing ? franck92 02/09/16 04:24:04 PM
#97818   yep let s imagine Coopervision has not made franck92 02/09/16 03:09:38 PM
#97817   Well...it was THE company...the only company; and unfortunately gr8f1 02/09/16 03:04:05 PM
#97816   I'm pleased that EPGL got Cooper to pay Scutterflux 02/09/16 02:59:58 PM
#97814   So how much did COO pay EPGL? Enough skorz 02/09/16 02:44:27 PM
#97813   More developments are coming. No toxic/convertible debt, H8ster 02/09/16 02:33:25 PM
#97812   Huge WIN on Settlement for $EPGL!! $COO #IoT vikingzskillz 02/09/16 02:32:59 PM
#97811   EP Global Communications, Inc. Reaches Settlement Agreement with vikingzskillz 02/09/16 02:25:24 PM
#97810   You can say what you want , there franck92 02/09/16 02:14:27 PM
#97809   Says who besides epgl is my point KBing617 02/09/16 01:43:42 PM
#97808   great post. Atlanta1 02/09/16 12:58:21 PM
#97807   how come , we never heard about any nowy257 02/09/16 12:56:09 PM
#97806   YOU have no idea what happened. This notion skorz 02/09/16 12:52:29 PM
#97805   "Can't wait for the first "sham" product ; Donguri 02/09/16 12:30:36 PM
#97804   Settlement Agreement, Can be viewed many ways AJCash 02/09/16 12:03:59 PM
PostSubject